Fig. 3From: Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neuronsEffect of inhibition or deficiency of Nox2 activity on the function and viability of dopaminergic neurons after exposure to WT or mutated A29-V40 peptides or LPS. a Changes in the ability of rat neuron-glia cultures to take up 3H-labeled DA after exposure to WT α-Syn peptide A29-V40, its corresponding mutant A29-V40 (A30P), or LPS in the presence or absence of the Nox2 inhibitor apocynin (Apo). b Changes in the number of TH-positive neurons in rat neuron-glia cultures after exposure to WT α-Syn peptide A29-V40, its corresponding mutant A29-V40 (A30P), or LPS in the presence or absence of Apo. c Changes in the ability of WT or gp91phox−/− mouse neuron-glia cultures to take up 3H-labeled DA after exposure to WT α-Syn peptide A29-V40 and its corresponding mutant A29-V40 (A30P). d Changes in the number of TH-positive neurons in WT or gp91phox−/− mouse neuron-glia cultures after exposure to WT α-Syn peptide A29-V40 and its corresponding mutant A29-V40 (A30P). In a, b, two-way ANOVA and Bonferroni’s post hoc test were performed. n = 5; *P < 0.05, **P < 0.01, ***P < 0.001, compared with the corresponding DMSO-treated controls; # P < 0.05 and ## P < 0.01, compared as indicated. In c, d, one-way ANOVA and Dunnett’s test were performed. n = 5; *P < 0.05, **P < 0.01, compared with the corresponding basal controlsBack to article page